PMID- 30237900 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220321 IS - 2056-5909 (Print) IS - 2056-5909 (Electronic) IS - 2056-5909 (Linking) VI - 24 DP - 2018 TI - Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT(-/-) mouse model of preeclampsia. PG - 11 LID - 10.1186/s40885-018-0097-1 [doi] LID - 11 AB - BACKGROUND: Preeclampsia (PE) is a serious maternal complication during pregnancy. Associated arterial stiffness in PE patients leads to increased risks of cardiovascular diseases later in life. Cholesterol efflux capacity, especially ATP binding cassette transporter A1 (ABCA1) dependent capacity, has been proposed to be a likely mediator of arterial stiffness. In the present study, we aimed to evaluate the effect of an apolipoprotein A1 mimetic peptide ATI-5261 on arterial stiffness in a mouse model of PE. METHODS: Pregnant COMT(-/-) mice were randomized to receive vehicle or ATI-5261 (30 mg/kg per day) via subcutaneous injection from gestational days (GD) 10.5 to GD 18.5 or to 10 days postpartum. Pregnant C57BL/6 J mice received vehicle during paralleled periods were served as normal controls. RESULTS: COMT(-/-) mice displayed maternal hypertension and proteinuria during pregnancy. Carotid-femoral pulse wave velocity (PWV) was increased at GD 18.5 and 10 days postpartum. ATI-5261 treatment in COMT(-/-) mice significantly reduced PWV and partially normalized impaired ex vivo vascular function at late pregnancy and early postpartum. ATI-5261 treatment also increased serum ABCA1 concentrations and cholesterol efflux capacity, as well as ABCA1 expressions in the placenta. Pup weights, crown to rump lengths and abdominal circumferences were reduced in COMT(-/-) mice. Treatment with ATI-5261 did not alter these fetal measurements but significantly reduced placental weights and increased fetal to placental ratios in COMT(-/-) mice. CONCLUSION: ATI-5261 reversed arterial stiffness at late pregnancy and early postpartum in a COMT(-/-) mouse model of PE and may be a potential therapy for arterial stiffness associated with PE. FAU - Liao, Shutan AU - Liao S AD - 1Rural Clinical School, University of New South Wales, Sydney, NSW Australia. ISNI: 0000 0004 4902 0432. GRID: grid.1005.4 AD - 2The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. GRID: grid.412615.5 FAU - Wu, Hao AU - Wu H AD - 3Chashan Teaching Centre, Department of Physiology, Wenzhou Medical University, Wenzhou, 325035 Zhejiang China. ISNI: 0000 0001 0348 3990. GRID: grid.268099.c FAU - Chen, Ruiying AU - Chen R AUID- ORCID: 0000-0002-7176-6500 AD - 3Chashan Teaching Centre, Department of Physiology, Wenzhou Medical University, Wenzhou, 325035 Zhejiang China. ISNI: 0000 0001 0348 3990. GRID: grid.268099.c LA - eng PT - Journal Article DEP - 20180915 PL - England TA - Clin Hypertens JT - Clinical hypertension JID - 101669508 PMC - PMC6138905 OTO - NOTNLM OT - Apolipoprotein A1 OT - Arterial stiffness OT - Cholesterol efflux OT - Mice OT - Preeclampsia OT - Pulse wave velocity COIS- This study was performed in accordance to the Guide for the Care and Use of Laboratory Animals published by the US NIH. All protocols were approved by the Animal Ethics Committee of Wenzhou Medical University (WZU38479-567).Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2018/09/22 06:00 MHDA- 2018/09/22 06:01 PMCR- 2018/09/15 CRDT- 2018/09/22 06:00 PHST- 2018/06/27 00:00 [received] PHST- 2018/08/09 00:00 [accepted] PHST- 2018/09/22 06:00 [entrez] PHST- 2018/09/22 06:00 [pubmed] PHST- 2018/09/22 06:01 [medline] PHST- 2018/09/15 00:00 [pmc-release] AID - 97 [pii] AID - 10.1186/s40885-018-0097-1 [doi] PST - epublish SO - Clin Hypertens. 2018 Sep 15;24:11. doi: 10.1186/s40885-018-0097-1. eCollection 2018.